Picture of Billions Co logo

044480 Billions Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Annual income statement for Billions Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
R2022
December 31st
R2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue13,04925,76470,64928,98741,725
Cost of Revenue
Gross Profit2,4193,71419,1765,8226,435
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses21,00251,00077,21827,26046,080
Operating Profit-7,953-25,236-6,5701,727-4,355
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-26,523-31,836-4,3902,397-1,951
Provision for Income Taxes
Net Income After Taxes-26,523-30,692-4,4522,387-1,951
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-26,667-29,489-18,864-13,813-1,964
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-26,667-29,489-18,864-13,813-1,964
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1,378-58611514-242
Dividends per Share